Component
Indicaxanthin exposure in rat brain
Experimental species, exposure and limitations are retained on each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
After oral indicaxanthin, rat whole-brain content peaked at 20 +/- 2.4 ng at 2.5 hours.
Experimental context and source evidence
- dose
- Indicaxanthin 2 micromol/kg
- duration
- Detected within 1 h, peak at 2.5 h, disappearance by approximately 4 h
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Rats given purified indicaxanthin
- limitations
- Brain exposure in rats does not demonstrate human BBB transport, clinical neuroprotection or neuronal target engagement.
- nutrient_topic
- Dedicated indicaxanthin chapter; original betalain family identity and shared claims preserved. · Indicaxanthin
- organism
- Rats given purified indicaxanthin
- plain_language
- After oral indicaxanthin, rat whole-brain content peaked at 20 +/- 2.4 ng at 2.5 hours.
- primary_references
- Indicaxanthin from Opuntia ficus-indica Crosses the Blood-Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. (2015). https://pubmed.ncbi.nlm.nih.gov/26227670/ DOI: 10.1021/acs.jafc.5b02612
- route
- Oral administration
- tissue
- Whole brain
Indicaxanthin: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 195–204
Original AI-assisted curation of thirteen additional primary studies, with twenty-six existing claims from eight studies linked unchanged. Study-specific citations and limitations retained. Not publisher full text. · supports · Rats given purified indicaxanthin · source_derived_draft · unverified_draft
## indicaxanthin-rat-brain-exposure After oral indicaxanthin, rat whole-brain content peaked at 20 +/- 2.4 ng at 2.5 hours. Model/species: Rats given purified indicaxanthin Tissue: Whole brain Exposure: Indicaxanthin 2 micromol/kg Route: Oral administration Duration: Detected within 1 h, peak at 2.5 h, disappearance by approximately 4 h Limits: Brain exposure in rats does not demonstrate human BBB transport, clinical neuroprotection or neuronal target engagement. Primary reference: Indicaxanthin from Opuntia ficus-indica Crosses the Blood-Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. (2015). https://pubmed.ncbi.nlm.nih.gov/26227670/ DOI: 10.1021/acs.jafc.5b02612 Access: Primary PubMed abstract.
Complete structured claim and evidenceAfter oral indicaxanthin, pigment was detected in rat cortex, hippocampus, diencephalon, brainstem and cerebellum, but not the striato-pallidal complex.
Experimental context and source evidence
- dose
- Indicaxanthin 2 micromol/kg
- duration
- Tissue sampling 1 h after dosing
- evidence_access
- Primary PubMed abstract; 2018 regional neuronal results additionally inspected in PMC full text.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Rats given purified indicaxanthin
- limitations
- Measured regional distribution must not be conflated with local-injection electrophysiology; human brain exposure is unproven.
- nutrient_topic
- Dedicated indicaxanthin chapter; original betalain family identity and shared claims preserved. · Indicaxanthin
- organism
- Rats given purified indicaxanthin
- plain_language
- After oral indicaxanthin, pigment was detected in rat cortex, hippocampus, diencephalon, brainstem and cerebellum, but not the striato-pallidal complex.
- primary_references
- Brain Distribution and Modulation of Neuronal Excitability by Indicaxanthin From Opuntia Ficus Indica Administered at Nutritionally-Relevant Amounts. (2018). https://pubmed.ncbi.nlm.nih.gov/29867444/ DOI: 10.3389/fnagi.2018.00133
- route
- Oral administration
- tissue
- Regional brain tissue
Indicaxanthin: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 228–237
Original AI-assisted curation of thirteen additional primary studies, with twenty-six existing claims from eight studies linked unchanged. Study-specific citations and limitations retained. Not publisher full text. · supports · Rats given purified indicaxanthin · source_derived_draft · unverified_draft
## indicaxanthin-rat-regional-distribution After oral indicaxanthin, pigment was detected in rat cortex, hippocampus, diencephalon, brainstem and cerebellum, but not the striato-pallidal complex. Model/species: Rats given purified indicaxanthin Tissue: Regional brain tissue Exposure: Indicaxanthin 2 micromol/kg Route: Oral administration Duration: Tissue sampling 1 h after dosing Limits: Measured regional distribution must not be conflated with local-injection electrophysiology; human brain exposure is unproven. Primary reference: Brain Distribution and Modulation of Neuronal Excitability by Indicaxanthin From Opuntia Ficus Indica Administered at Nutritionally-Relevant Amounts. (2018). https://pubmed.ncbi.nlm.nih.gov/29867444/ DOI: 10.3389/fnagi.2018.00133 Access: Primary PubMed abstract; 2018 regional neuronal results additionally inspected in PMC full text.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.